One hundred days or more bridged on a ventricular assist device and effects on outcomes following heart transplantation.

[1]  N. Smedira,et al.  Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  M. Loebe,et al.  Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  O. Frazier,et al.  Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease? , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  N. Smedira,et al.  Early and Midterm Risk of Coronary Allograft Vasculopathy in Patients Bridged to Orthotopic Heart Transplantation with Ventricular Assist Devices , 2005, Transplantation.

[5]  A. Westfall,et al.  Relationship between bridging with ventricular assist device on rejection after heart transplantation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  Bartley P Griffith,et al.  LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[7]  Benjamin C. Sun,et al.  Indications for long-term assist device placement as bridge to transplantation. , 2003, Cardiology clinics.

[8]  P. McCarthy,et al.  Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. , 2001, The Annals of thoracic surgery.

[9]  L. Harrison,et al.  Relapsing bacteremia in patients with ventricular assist device: an emergent complication of extended circulatory support. , 2001, The Annals of thoracic surgery.

[10]  R. Cody,et al.  Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  M. Oz,et al.  Infections During Left Ventricular Assist Device Support Do Not Affect Posttransplant Outcomes , 2000, Circulation.

[12]  R. Bolman,et al.  Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. , 2000, The Annals of thoracic surgery.

[13]  M. Oz,et al.  Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. , 1999, Circulation.

[14]  Silviu Itescu,et al.  Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist de vice , 1999, The Lancet.

[15]  W. von Scheidt,et al.  Cardiac allograft vasculopathy: a review. , 1997, Circulation.

[16]  M. Oz,et al.  The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  H. Scheld,et al.  Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. , 1997, Circulation.

[18]  A. Pavie,et al.  The Concerted Action 'Heart' European registry on clinical application of mechanical circulatory support systems: bridge to transplant. The Registry Scientific Committee. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[19]  B. Griffith,et al.  Results of extended bridge to transplantation: window into the future of permanent ventricular assist devices. , 1996, The Annals of thoracic surgery.

[20]  D. McGiffin,et al.  Infections during extended circulatory support: University of Alabama at Birmingham experience 1989 to 1994. , 1996, The Annals of thoracic surgery.

[21]  P. McCarthy,et al.  Implantable LVAD infections: implications for permanent use of the device. , 1996, The Annals of thoracic surgery.